Medicare Enrolled

Dr. Aaron Carter, MD

Pain Medicine · Greenville, NC
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
2430 EMERALD PL STE 201, Greenville, NC 27834
2527522140
In practice since 2007 (18 years)
NPI: 1528247806 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Carter from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Carter? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Carter

Dr. Aaron Carter is a pain medicine specialist in Greenville, NC, with 18 years of NPI registration. Based on federal Medicare data, Dr. Carter performed 1,126 Medicare services across 878 unique beneficiaries.

Between the years covered by Open Payments, Dr. Carter received a total of $8,964 from 38 pharmaceutical and/or device companies across 310 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Carter is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 23% volume in NC $8,964 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,126
Medicare services
Top 23% in NC for pain medicine
878
Unique beneficiaries
$95
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~63 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
303 $61 $388
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
197 $85 $578
Injection into lower spine canal with imaging guidance
A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement.
81 $178 $2,669
Injection, methylprednisolone acetate, 40 mg 78 $6 $26
Methylprednisolone acetate injection, 80 mg
An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication.
66 $9 $48
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
56 $117 $964
Drug screening test
A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample.
51 $61 $352
Facet joint nerve destruction, additional joint
This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint.
50 $182 $1,800
Facet joint nerve destruction, single joint
A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals.
44 $330 $2,750
Definitive drug test using GC/MS or LC/MS
A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS.
38 $195 $445
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
32 $80 $771
Contrast dye for imaging, lower concentration 26 $0 $1
Spine facet joint injection with imaging guidance, single level
An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement.
24 $176 $4,065
Ultrasound-guided large joint aspiration or injection
This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint.
22 $78 $1,129
Facet joint injection, second level, with imaging guidance
An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated.
22 $100 $2,187
Injection of anesthetic or steroid into sacroiliac joint with imaging guidance
This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection.
20 $131 $1,688
Spinal injection with imaging guidance
A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location.
16 $165 $2,905
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$8,964
Total received (2018-2024)
Avg $1,281/year across 7 years
Top 23% in NC for pain medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
310
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,964 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,016
2023
$2,302
2022
$451
2021
$549
2020
$514
2019
$1,068
2018
$2,064

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
SPR Therapeutics, Inc
$754
Medtronic, Inc.
$452
SI-BONE, INC.
$333
Boston Scientific Corporation
$135
Collegium Pharmaceutical, Inc.
$134
PAINTEQ LLC
$108
Saluda Medical Americas, Inc.
$33
ABBVIE INC.
$27
Virtus Pharmaceuticals LLC
$24
PROTEGA PHARMACEUTIALS INC
$16
Top 3 companies account for 76.3% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic USA, Inc.
$1,626
Medtronic, Inc.
$1,343
Curonix LLC
$1,320
SPR Therapeutics, Inc
$754
Forte Bio-Pharma LLC
$723
Saluda Medical Americas, Inc.
$417
Collegium Pharmaceutical, Inc.
$358
SI-BONE, INC.
$357
Boston Scientific Corporation
$347
PFIZER INC.
$219
BOSTON SCIENTIFIC CORPORATION
$146
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$136
Sentynl Therapeutics, Inc.
$110
PAINTEQ LLC
$108
SCILEX PHARMACEUTICALS INC.
$91
RedHill Biopharma Inc.
$85
AstraZeneca Pharmaceuticals LP
$77
BioDelivery Sciences International, Inc.
$76
Nevro Corp.
$72
Vertos Medical, Inc.
$70
SI-BONE, Inc.
$55
Virtus Pharmaceuticals LLC
$52
Almatica Pharma LLC
$48
Daiichi Sankyo Inc.
$46
ARBOR PHARMACEUTICALS, INC.
$41
GRT US Holding, Inc.
$32
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$30
Abbott Laboratories
$30
Arbor Pharmaceuticals, Inc.
$30
ABBVIE INC.
$27
Scilex Pharmaceuticals Inc.
$24
FIDIA PHARMA USA INC.
$22
Azurity Pharmaceuticals, Inc.
$20
INSYS Therapeutics Inc
$16
Bausch Health US, LLC
$16
PROTEGA PHARMACEUTIALS INC
$16
Shionogi Inc
$13
Purdue Pharma L.P.
$12
Top 3 companies account for 47.9% of all-time payments
Associated products mentioned in payments ›
ADAPTIVESTIM · BELBUCA · BOTOX · BUNAVAIL 2.1 mg 30-count box · Belbuca · Evoke · Evoke SCS · FLECTOR · GRALISE · General - Therapies · Horizant · Hymovis · INTELLIS · INTELLIS ADAPTIVESTIM · KYPHON Balloon Kyphoplasty · KYPHON EXPRESS II KYPHOPAK TRAY · LEVORPHANOL TARTRATE · LYRICA · Levorphanol · Levorphanol Tartrate · MIGRANAL · MOVANTIK · Morphabond ER · Movantik · NALOCET · Nalocet · Neuromodulation Dspsbls and Accs · Nucynta · Omnia · PAINTEQ · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · Proclaim Family of SCS IPGs · Qutenza · RELISTOR · RELISTOR ORAL · RESTORE · ROXYBOND · SPECTRA WAVEWRITER · SPRINT PNS System · SUBSYS · SYMPROIC · Symproic · VECTRIS · WaveWriter Alpha Prime 16 · XTAMPZA · XTAMPZAER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · iFuse Implant · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a pain medicine specialist in Greenville?
Compare pain medicines in the Greenville area by procedure volume, costs, and industry payment transparency.
Browse pain medicines nearby

Geographic Context

Pain medicines within 10 mi
5
Per 100K population
2.9
County median income
$58,851
Nearest hospital
ECU HEALTH MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Carter is a clinical cardiology specialist, with above-average Medicare volume (top 23% in NC), with low-engagement industry engagement, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Carter experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Carter performed 303 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Carter receive payments from pharmaceutical companies?
Yes. Dr. Carter received a total of $8,964 from 38 companies across 310 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Carter's costs compare to other pain medicines in Greenville?
Dr. Carter's average Medicare payment per service is $95. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Carter) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →